Zuventus Healthcare Limited, Mumbai
Dr. Mukesh Shinde is a seasoned professional in the pharmaceutical industry, currently serving as Manager and Senior Research Scientist at Zuventus Healthcare Limited since July 2012. With extensive experience in formulation development, process development, bioequivalence studies, and clinical trials for solid oral, semisolid, nasal, and probiotic formulations, Dr. Shinde has led numerous technology transfers and collaborated with vendors on innovative ingredients and processes. Prior roles include Assistant Manager and Executive at Zuventus, Research Fellow at Emcure Pharmaceuticals, and Officer at Agio Pharmaceuticals, all contributing to a robust foundation in pharmaceutical sciences. Dr. Shinde holds a PhD in Modified Release Formulation Development by Quality by Design from Parul University, along with an M.Pharm in Pharmaceutics and a B.Pharm in Pharmaceutical Sciences.
This person is not in any offices
Zuventus Healthcare Limited, Mumbai
The journey of Zuventus Healthcare began in 2002 when a visionary with pharmaceutical expertise instituted a pharma venture for developing therapeutic products that would improve people’s health, aid faster recovery, and empower them to lead quality lives. The mainstays of this concept were – paramount emphasis on quality, ethics, compliance to standards in operations, and making affordable medicines. A concept whose foundations were as strong as these and which was driven by an unshakeable conviction to care for life inevitably reaches its goal. From 400 employees in 2002 to 3000+ employees today, Zuventus Healthcare is the fastest growing pharma company in India with effective and robust product lines covering a range of therapeutic segments including anti-infectives, vitamins/minerals/nutrients, respiratory generics, gastrointestinal, cardiac, gynaecological, pain/analgesic, antidiabetic, cephalosporins and more available in multiple dosages forms such as tablets, capsules, injectables, and liquids. Zuventus has strong manufacturing capabilities based in Jammu, Sikkim, and Bengaluru as well as a DSIR-approved, advanced formulation R & D centre in Pune. Zuventus’s stupendous growth is evident from the fact that – the company crossed the “100-crore” mark in April 2006, the “200-crore” mark in September 2007 and were quick to achieve a turnover of 2000 crores in 20 years. Today, the company is ranked 7th in the directly covered market and overall ranked 23rd amongst the leading pharmaceutical companies in India. As we propel ahead, we will continue to push the boundaries, invest in research and technology to develop drugs and vaccines for improving patients’ wellbeing.